Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2025-12-25 @ 2:14 AM
NCT ID:
NCT04166760
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years
* Type 2 diabetes (T2D) diagnosis
* No medical treatment or metformin/sulfonylureas(SU) alone in the treatment of T2D
* No daily use of protein drinks
* Hba1c between 40 mmol/mol and 69 mmol/mol
* 20 kg/m2 \< BMI \< 35 kg/m2
* Screening blood test: 1200 pmol/l \> C-peptid \> 370 pmol/l
Exclusion Criteria:
* Other diabetes medication than metformin/SU (e.g. insulin, GLP-1 analog, DPP-4 inhibitor, SGLT2-inhibitor)
* Affected screening blood test assessed by the primary investigator(PI)/sponsor
* Does not understand or speak danish
* Milk allergy
* PI finds the patient not fit (e.g. mental illness, too nervous or other)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04166760
Study Brief:
Protocol Section:
NCT04166760